Delivery Order SPE2DB20D3103-SPE2DB25FP8B8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges valued at $20,917.11. This firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is executed as a child...
- The Defense Logistics Agency awarded a delivery order valued at $12,487.60 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml cartridges on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract represents a non-set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Imitrex is a migraine treatment medication, and this delivery order fulfills specific pharmaceutical supply needs for federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $6,600.81 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award for pharmaceutical supplies to be delivered to the Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,062.66 firm fixed-price contract is for the supply of Imitrex 6 mg/0.5 ml cartridges to support U.S. government medical requirements. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. There is no set-aside designation noted for this award. Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.54 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitive award carries firm fixed pricing and involves no set-aside designation. The pharmaceutical product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,521.52, is for the supply of Imitrex 6 mg/0.5 ml cartridges to support federal healthcare programs. The contract has a firm fixed price and an ultimate completion date of September 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,179.74 firm fixed-price delivery order is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a $5,036.17 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp to provide 4,564,220,914 units of Imitrex 6 mg/0.5 ml cartridges. This contract has an ultimate completion date of April 10, 2024 and was not set aside for any specific business category. AmerisourceBergen, a for-profit pharmaceutical distributor, is a key vendor for federal healthcare programs, particularly supporting military and veterans' medical needs through major...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The $1,560.95 fixed-price contract has an ultimate completion date of August 21, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a firm fixed price of $12,124.38 and a completion date of March 7, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8B8Delivery Order
The Defense Logistics Agency (DLA) awarded a $5,155.59 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges (0.5 mL units). This firm fixed-price contract represents a non-competitive delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated capability to meet federal procurement requirements through open competition, consistently winning delivery orders across a diverse portfolio of medications and medical supplies for Defense Health Agency and other federal healthcare systems. The Imitrex delivery under this IDC reflects the company's ongoing role in supporting critical pharmaceutical needs for military personnel and veterans, with the underlying contract vehicle enabling flexible procurement of specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/8/25 |